Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Faiza Gaba +442035942053
faiza.gaba1@abdn.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer

Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer

Recruiting

Open to: FEMALE

Age: 18.0 - N/A

Medical Conditions

Ovarian Neoplasms
Carcinoma, Ovarian Epithelial


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


To compare patient outcomes following interval and delayed cytoreductive surgeries and no surgery (neoadjuvant chemotherapy alone) and international variations in access to cytoreductive surgeries in women with advanced stage ovarian cancer.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Aug 2022 Dec 2023

Publications

"Gaba F, Ash K, Blyuss O, Bizzarri N, Kamfwa P, Ramirez PT, Kotsopoulos IC, Chandrasekaran D, Gomes N, Butler J, Nobbenhuis M, Ind T, Heath O, Barton D, Jeyarajah A, Brockbank E, Lawrence A, Dilley J, Manchanda R, Phadnis S, Soar GO. Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative). Int J Gynecol Cancer. 2022 Dec 5;32(12):1606-1610. doi: 10.1136/ijgc-2022-004101."; "36379595"

OBSERVATIONAL

Intervention Type : PROCEDURE
Intervention Description : cytoreductive surgery after 3-4 cycles of chemotherapy

Intervention Arm Group : interval cytoreductive surgery;

Intervention Type : PROCEDURE
Intervention Description : surgery after \>5 cycles of chemotherapy

Intervention Arm Group : delayed cytoreductive surgery;

Intervention Type : OTHER
Intervention Description : no cytoreductive surgery (\>5 cycles of chemotherapy alone)

Intervention Arm Group : no surgery;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • The Royal London Hospital
    London
    E1 1FR


The study is sponsored by NHS Grampian and is in collaboration with University of Aberdeen; Barts & The London NHS Trust; Queen Mary University of London.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT05523804
Last updated 30 August 2022

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.